[Clinical development of the first erythropoietin registered according to its European development and biological similarity].
Canaud
B
B
Service de néphrologie, Hôpital Lapeyronie, 191 avenue Doyen Gaston Giraud, 34295 Montpellier cedex 5, France.
D000368:Aged; D004361:Drug Tolerance; D004921:Erythropoietin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards / Q000627:therapeutic use*; D005060:Europe; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D013810:Therapeutic Equivalency
D011994:Recombinant Proteins; D004921:Erythropoietin